Entity type
Company
Filer Snapshot
Medicxi IV LP
CIK 0001929290. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Total filings
1
Latest filing
06 Jan 2025
Industry
n/a
Filing-backed research brief
Start with the SEC data that changes for this CIK
Latest signal: 13D/G stake for RAPT. Each card links back to the PortfolioSavvy page where the filing evidence is closest.
Latest 13F portfolio
—
No parsed 13F portfolio row yet.
Browse latest 13FLargest parsed holding
—
Populates from the latest parsed 13F information table.
Open holding13D/G large stake
RAPT
27 Dec 2024 · 17% ownership
Open 13D/GInsider / owner context
—
No parsed Forms 3/4/5 owner position for this CIK.
Browse insider filingsSave this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Source: SEC Schedule 13D/G
View Source Filing
SCHEDULE 13G filed on 06 Jan 2025 for CIK 0001929290.
- Ownership signals
-
Schedule 13G positions
Passive or institutional large-stake positions disclosed in parsed Schedule 13G filings.
RAPTHow to read these SEC values
- Read each filing type on its own: 13F portfolios, 13D/G large stakes, and Forms 3/4/5 owner positions answer different questions.
- Open the linked research paths when you need to verify the exact SEC filing behind a value.
- Business address
- C/O Intertrust Fund Services (Jersey), 44 Esplanade, St Helier, Jersey, JE4 9WG
- State of incorporation
- Jersey
Ownership signals
1 signal
Identity
1 identity field
SEC profile 1 profile field
Filer intelligence
What SEC filings say about Medicxi IV LP
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
Quick read
- 1 recent 13D/G stake row found; top row is RAPT at 17% ownership.
SEC source mix
Counts show available parsed rows, not one combined ownership total.
13D/G large-stake context
RAPT
27 Dec 2024 · Common Stock, $0.0001 par value
Latest update
What changed recently for Medicxi IV LP
Latest Schedule 13D/G period: 27 Dec 2024. Open the source-backed page to inspect the fresh filing or facts context.
Update date
06 Jan 2025
Page type
Filer profile
Latest period
27 Dec 2024
Schedule 13D/G context is visible from filings filed on 06 Jan 2025.
Benchmark Context
Benchmark context for this company
Medicxi IV LP has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.
Compared with
Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.
Why this is notable
Latest Schedule 13D/G period: 27 Dec 2024. That gives you a fresh baseline before you compare this company with peers.
- Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
- Open the facts page first if you want the cleanest path to verification.
Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.
SEC filing record
CIK 0001929290 filing coverage
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
SEC filings
1
First seen
06 Jan 2025
Latest filing
06 Jan 2025
Entity
Company
Observed form types
SCHEDULE 13G
CIK-linked evidence first
Latest Filings
Showing the latest 1 of 1 SEC filings for Medicxi IV LP.
SCHEDULE 13G
SCHEDULE 13G filing
- Filing date
- 06 Jan 2025
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing